Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,052 | 10,792 | 12,362 | 13,897 | 1,564 |
| Receivables | 431 | 643 | 287 | 382 | 351 |
| TOTAL | $12,718 | $11,513 | $12,761 | $14,387 | $2,072 |
| Non-Current Assets | |||||
| Intangibles | 1,952 | 1,978 | 2,003 | 2,028 | 2,054 |
| Other Non-Current Assets | 41 | 40 | 41 | 39 | 39 |
| TOTAL | $1,993 | $2,018 | $2,044 | $2,067 | $2,092 |
| Total Assets | $14,710 | $13,531 | $14,805 | $16,454 | $4,164 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 756 | 1,079 | 673 | 915 | 1,900 |
| TOTAL | $756 | $1,079 | $673 | $915 | $1,900 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $756 | $1,079 | $673 | $915 | $1,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,348 | 8,334 | 7,038 | 7,023 | 6,936 |
| Common Shares | 57,900 | 54,515 | 54,271 | 54,271 | 47,562 |
| Retained earnings | -68,196 | -65,911 | -63,645 | -61,859 | -60,232 |
| Other shareholders' equity | -171 | -166 | -123 | -288 | -224 |
| TOTAL | $13,954 | $12,452 | $14,132 | $15,540 | $2,264 |
| Total Liabilities And Equity | $14,711 | $13,531 | $14,805 | $16,454 | $4,164 |